Sangamo Biosciences reported $118.53M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Alnylam Pharmaceuticals ALNY:US $ 605.96M 89.75M
Amgen AMGN:US $ 12886M 702M
Avrobio Inc AVRO:US $ 17.13M 2.26M
Bayer BAYN:GR € 31019M 1616M
Biocryst Pharmaceuticals BCRX:US $ 81.02M 22.7M
Biogen BIIB:US $ 3946.6M 351.6M
Biomarin Pharmaceutical BMRN:US $ 490.42M 49.4M
Bluebird Bio BLUE:US $ 142.89M 10.1M
Gilead Sciences GILD:US $ 8558M 3052M
GlaxoSmithKline GSK:LN 24278M 608M
Intercept Pharmaceuticals ICPT:US $ 151.04M 15.78M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Johnson & Johnson JNJ:US $ 43390M 1836M
Karyopharm Therapeutics KPTI:US $ 66.34M 7.38M
Merk MRK:US $ 22316M 1556M
Novartis NOVN:VX SF 29807M 401M
Omeros OMER:US $ 35.07M 16.72M
Pfizer PFE:US $ 39268M 3403M
Regulus Therapeutics RGLS:US $ 4.7M 0.53M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Sarepta Therapeutics SRPT:US $ 454.96M 2.23M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M
Vertex Pharmaceuticals VRTX:US $ 2180.2M 38.2M
Ziopharm Oncology ZIOP:US $ 21.23M 5.19M